Prognostic significance of autoimmunity during treatment of melanoma with interferon. (Record no. 16093425)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02099 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515014915.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200602s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1533-4406 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1056/NEJMoa053007 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gogas, Helen |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20060221 |
| 245 00 - TITLE STATEMENT | |
| Title | Prognostic significance of autoimmunity during treatment of melanoma with interferon. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The New England journal of medicine |
| Date of publication, distribution, etc. | Feb 2006 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 709-18 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adjuvants, Immunologic |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Analysis of Variance |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Autoantibodies |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Autoimmunity |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemotherapy, Adjuvant |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon alpha-2 |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Melanoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proportional Hazards Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recurrence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Skin Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Analysis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ioannovich, John |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dafni, Urania |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stavropoulou-Giokas, Catherine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Frangia, Konstantina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsoutsos, Dimosthenis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Panagiotou, Petros |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Polyzos, Aristidis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Papadopoulos, Othonas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stratigos, Alexandros |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Markopoulos, Christos |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bafaloukos, Dimitrios |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pectasides, Dimitrios |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fountzilas, George |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kirkwood, John M |
| 773 0# - HOST ITEM ENTRY | |
| Title | The New England journal of medicine |
| Related parts | vol. 354 |
| -- | no. 7 |
| -- | p. 709-18 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMoa053007">https://doi.org/10.1056/NEJMoa053007</a> |
| Public note | Available from publisher's website |
No items available.